Tag: interim

Daix (France), New York City (New York, United States), July 9, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced a leadership transition with the appointment of Jason Campagna, MD, PhD, as President of Research and Development (“R&D”) and Chief Medical Officer (“CMO”) and Martine Zimmermann, PharmD, as Executive Vice President (“EVP”) of Regulatory Affairs and Quality Assurance.

Data from Orbit and Cosmic studies expected around the end of the year

Ekopak (EKOP:xbru), a company specialized in circular water solutions, announces the appointment of Jean-Baptiste De Cuyper as its new CEO. This appointment follows the earlier communication of May 12, 2025, in which the company announced its intention to appoint an external candidate for this key role. The appointment is part of Ekopak's broader efforts to strengthen its governance and management structure.

Ekopak (EKOP:xbru), een onderneming gespecialiseerd in circulaire wateroplossingen, kondigt de benoeming aan van Jean-Baptiste De Cuyper als nieuwe CEO. Deze aanstelling volgt op de eerdere communicatie van 12 mei 2025 waarin het bedrijf haar intentie bekendmaakte om een externe kandidaat aan te stellen voor deze sleutelrol. De benoeming past binnen Ekopak’s bredere inspanningen om haar governance en managementstructuur te versterken.

Not for dissemination in the United States of America